{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:07:55Z","timestamp":1768554475176,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s40272-013-0063-z","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T15:17:30Z","timestamp":1389107850000},"page":"169-177","source":"Crossref","is-referenced-by-count":51,"title":["Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity"],"prefix":"10.1007","volume":"16","author":[{"given":"Katherine","family":"Schoen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Stockmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Spigarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M. T.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"issue":"6","key":"63_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1891\/0730-0832.19.6.17","volume":"19","author":"K Theobald","year":"2000","unstructured":"Theobald K, Botwinski C, Albanna S, et al. Apnea of prematurity: diagnosis, implications for care, and pharmacologic management. Neonatal Netw. 2000;19(6):17\u201324.","journal-title":"Neonatal Netw"},{"issue":"9","key":"63_CR2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00431-011-1409-6","volume":"170","author":"J Zhao","year":"2011","unstructured":"Zhao J, Gonzalez F, Mu D. Apnea of prematurity: from cause to treatment. Eur J Pediatrics. 2011;170(9):1097\u2013105.","journal-title":"Eur J Pediatrics."},{"issue":"1","key":"63_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1542\/peds.50.1.40","volume":"50","author":"ER Alden","year":"1972","unstructured":"Alden ER, Mandelkorn T, Woodrum DE, et al. Morbidity and mortality of infants weighing less than 1,000 grams in an intensive care nursery. Pediatrics. 1972;50(1):40\u20139.","journal-title":"Pediatrics"},{"issue":"4 Pt 1","key":"63_CR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/01.pdr.0000203105.63246.8a","volume":"59","author":"G Montandon","year":"2006","unstructured":"Montandon G, Bairam A, Kinkead R. Long-term consequences of neonatal caffeine on ventilation, occurrence of apneas, and hypercapnic chemoreflex in male and female rats. Pediatr Res. 2006;59(4 Pt 1):519\u201324.","journal-title":"Pediatr Res"},{"issue":"3","key":"63_CR5","first-page":"429","volume":"130","author":"GS Supinski","year":"1984","unstructured":"Supinski GS, Deal EC Jr, Kelsen SG. The effects of caffeine and theophylline on diaphragm contractility. Am Rev Respir Dis. 1984;130(3):429\u201333.","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"63_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0095-5108(18)31165-5","volume":"6","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Turmen T. Methylxanthines in apnea of prematurity. Clin Perinatol. 1979;6(1):87\u2013108.","journal-title":"Clin Perinatol"},{"issue":"6","key":"63_CR7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0022-3476(83)80735-5","volume":"103","author":"JV Aranda","year":"1983","unstructured":"Aranda JV, Turmen T, Davis J, et al. Effect of caffeine on control of breathing in infantile apnea. J Pediatrcs. 1983;103(6):975\u20138.","journal-title":"J Pediatrcs."},{"issue":"1","key":"63_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/1531-8249(199907)46:1<95::AID-ANA14>3.0.CO;2-1","volume":"46","author":"V Dzhala","year":"1999","unstructured":"Dzhala V, Desfreres L, Melyan Z, et al. Epileptogenic action of caffeine during anoxia in the neonatal rat hippocampus. Ann Neurol. 1999;46(1):95\u2013102.","journal-title":"Ann Neurol."},{"issue":"2","key":"63_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008571-199204000-00004","volume":"2","author":"L Gu","year":"1992","unstructured":"Gu L, Gonzalez FJ, Kalow W, et al. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics. 1992;2(2):73\u20137.","journal-title":"Pharmacogenetics."},{"issue":"5","key":"63_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/clpt.1993.63","volume":"53","author":"W Kalow","year":"1993","unstructured":"Kalow W, Tang BK. The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther. 1993;53(5):503\u201314.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"63_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-200039020-00004","volume":"39","author":"JA Carrillo","year":"2000","unstructured":"Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000;39(2):127\u201353.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"63_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2125.1995.tb04455.x","volume":"39","author":"HR Ha","year":"1995","unstructured":"Ha HR, Chen J, Freiburghaus AU, et al. Metabolism of theophylline by cDNA-expressed human cytochromes P-450. Br J Clin Pharmacol. 1995;39(3):321\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"63_CR13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/0006-2952(88)90423-6","volume":"37","author":"RA Robson","year":"1988","unstructured":"Robson RA, Miners JO, Matthews AP, et al. Characterisation of theophylline metabolism by human liver microsomes: inhibition and immunochemical studies. Biochem Pharmacol. 1988;37(9):1651\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"63_CR14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3476(79)80246-2","volume":"94","author":"C Bory","year":"1979","unstructured":"Bory C, Baltassat P, Porthault M, et al. Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr. 1979;94(6):988\u201393.","journal-title":"J Pediatr."},{"issue":"6","key":"63_CR15","doi-asserted-by":"crossref","first-page":"F499","DOI":"10.1136\/adc.2002.023432","volume":"89","author":"P Steer","year":"2004","unstructured":"Steer P, Flenady V, Shearman A, et al. High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F499\u2013503.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"63_CR16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1651-2227.2010.01828.x","volume":"99","author":"MB Tracy","year":"2010","unstructured":"Tracy MB, Klimek J, Hinder M, et al. Does caffeine impair cerebral oxygenation and blood flow velocity in preterm infants? Acta Paediatr. 2010;99(9):1319\u201323.","journal-title":"Acta Paediatr"},{"key":"63_CR17","doi-asserted-by":"crossref","unstructured":"Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev. 2010;(1):CD000273.","DOI":"10.1002\/14651858.CD000273.pub2"},{"issue":"6","key":"63_CR18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/FTD.0b013e3181898b6f","volume":"30","author":"BG Charles","year":"2008","unstructured":"Charles BG, Townsend SR, Steer PA, et al. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit. 2008;30(6):709\u201316.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"63_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00128072-200103010-00005","volume":"3","author":"AM Comer","year":"2001","unstructured":"Comer AM, Perry CM, Figgitt DP. Caffeine citrate: a review of its use in apnoea of prematurity. Paediatr Drugs. 2001;3(1):61\u201379.","journal-title":"Paediatr Drugs"},{"issue":"5","key":"63_CR20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.2006-2986","volume":"119","author":"G Natarajan","year":"2007","unstructured":"Natarajan G, Botica ML, Thomas R, et al. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics. 2007;119(5):936\u201340.","journal-title":"Pediatrics"},{"issue":"4","key":"63_CR21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0022-3476(87)80569-3","volume":"110","author":"A Bairam","year":"1987","unstructured":"Bairam A, Boutroy MJ, Badonnel Y, et al. Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant. J Pediatr. 1987;110(4):636\u20139.","journal-title":"J Pediatr"},{"issue":"7","key":"63_CR22","first-page":"698","volume":"139","author":"C Brouard","year":"1985","unstructured":"Brouard C, Moriette G, Murat I, et al. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants. Am J Dis Child. 1985;139(7):698\u2013700.","journal-title":"Am J Dis Child"},{"issue":"5","key":"63_CR23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1651-2227.1989.tb11147.x","volume":"78","author":"G Fuglsang","year":"1989","unstructured":"Fuglsang G, Nielsen K, Kjaer Nielsen L, et al. The effect of caffeine compared with theophylline in the treatment of idiopathic apnea in premature infants. Acta Paediatr Scand. 1989;78(5):786\u20138.","journal-title":"Acta Paediatr Scand"},{"key":"63_CR24","doi-asserted-by":"crossref","unstructured":"Scanlon JE, Chin KC, Morgan ME, et al. Caffeine or theophylline for neonatal apnoea? Arch Dis Child. 1992;67(4 Spec No):425\u20138.","DOI":"10.1136\/adc.67.4_Spec_No.425"},{"key":"63_CR25","first-page":"208A","volume":"31","author":"SP Kumar","year":"1992","unstructured":"Kumar SP, Mehta PN, Bradley BS, Ezhuthachan SG. Documented monitoring (DM) shows theophylline (T) to be more effective than caffeine (C) in prematurity apnea (PA). Pediatr Res. 1992;31:208A.","journal-title":"Pediatr Res"},{"issue":"2","key":"63_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-3732(97)00038-6","volume":"50","author":"B Laubscher","year":"1998","unstructured":"Laubscher B, Greenough A, Dimitriou G. Comparative effects of theophylline and caffeine on respiratory function of prematurely born infants. Early Human Dev. 1998;50(2):185\u201392.","journal-title":"Early Human Dev"},{"issue":"2","key":"63_CR27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/jp.2012.52","volume":"33","author":"RM Patel","year":"2013","unstructured":"Patel RM, Leong T, Carlton DP, et al. Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatol Off J Calif Perinatal Assoc. 2013;33(2):134\u201340.","journal-title":"J Perinatol Off J Calif Perinatal Assoc."},{"issue":"3","key":"63_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jpeds.2009.09.069","volume":"156","author":"PG Davis","year":"2010","unstructured":"Davis PG, Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr. 2010;156(3):382\u20137.","journal-title":"J Pediatr."},{"issue":"10","key":"63_CR29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1440-1754.2009.01570.x","volume":"45","author":"M Skouroliakou","year":"2009","unstructured":"Skouroliakou M, Bacopoulou F, Markantonis SL. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial. J Paediatr Child Health. 2009;45(10):587\u201392.","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"63_CR30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF00442697","volume":"147","author":"HU Bucher","year":"1988","unstructured":"Bucher HU, Duc G. Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial. Eur J Pediatr. 1988;147(3):288\u201391.","journal-title":"Eur J Pediatr"},{"issue":"20","key":"63_CR31","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112\u201321.","journal-title":"N Engl J Med"},{"issue":"19","key":"63_CR32","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893\u2013902.","journal-title":"N Engl J Med"},{"issue":"1","key":"63_CR33","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1542\/peds.2010-1014","volume":"127","author":"D Dukhovny","year":"2011","unstructured":"Dukhovny D, Lorch SA, Schmidt B, et al. Economic evaluation of caffeine for apnea of prematurity. Pediatrics. 2011;127(1):e146\u201355.","journal-title":"Pediatrics"},{"issue":"9","key":"63_CR34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00007611-198809000-00006","volume":"81","author":"JD McGowan","year":"1988","unstructured":"McGowan JD, Altman RE, Kanto WP Jr. Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J. 1988;81(9):1092\u20134.","journal-title":"South Med J"},{"issue":"5","key":"63_CR35","first-page":"495","volume":"134","author":"W Banner Jr","year":"1980","unstructured":"Banner W Jr, Czajka PA. Acute caffeine overdose in the neonate. Am J Dis Child. 1980;134(5):495\u20138.","journal-title":"Am J Dis Child"},{"issue":"2","key":"63_CR36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1542\/peds.64.2.254","volume":"64","author":"PB Kulkarni","year":"1979","unstructured":"Kulkarni PB, Dorand RD. Caffeine toxicity in a neonate. Pediatrics. 1979;64(2):254\u20135.","journal-title":"Pediatrics"},{"issue":"4","key":"63_CR37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1754.2010.01943.x","volume":"47","author":"PH Gray","year":"2011","unstructured":"Gray PH, Flenady VJ, Charles BG, et al. Caffeine citrate for very preterm infants: effects on development, temperament and behaviour. J Paediatr Child Health. 2011;47(4):167\u201372.","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"63_CR38","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1542\/peds.109.5.784","volume":"109","author":"C Hoecker","year":"2002","unstructured":"Hoecker C, Nelle M, Poeschl J, et al. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics. 2002;109(5):784\u20137.","journal-title":"Pediatrics"},{"issue":"4","key":"63_CR39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000243123","volume":"56","author":"E Saliba","year":"1989","unstructured":"Saliba E, Autret E, Gold F, et al. Effect of caffeine on cerebral blood flow velocity in preterm infants. Biol Neonate. 1989;56(4):198\u2013203.","journal-title":"Biol Neonate"},{"issue":"1","key":"63_CR40","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1136\/adc.2005.073866","volume":"91","author":"C Hoecker","year":"2006","unstructured":"Hoecker C, Nelle M, Beedgen B, et al. Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91(1):F61\u20134.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"63_CR41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00002018-200023050-00002","volume":"23","author":"JM Hascoet","year":"2000","unstructured":"Hascoet JM, Hamon I, Boutroy MJ. Risks and benefits of therapies for apnoea in premature infants. Drug Saf. 2000;23(5):363\u201379.","journal-title":"Drug Saf"},{"issue":"8","key":"63_CR42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archpedi.155.8.934","volume":"155","author":"JA Lowry","year":"2001","unstructured":"Lowry JA, Jarrett RV, Wasserman G, et al. Theophylline toxicokinetics in premature newborns. Arch Pediatr Adolesc Med. 2001;155(8):934\u20139.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-642-13443-2_14","volume":"200","author":"U Aden","year":"2011","unstructured":"Aden U. Methylxanthines during pregnancy and early postnatal life. Handb Exp Pharmacol. 2011;200:373\u201389.","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"63_CR44","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1136\/fn.83.1.F39","volume":"83","author":"VP Carnielli","year":"2000","unstructured":"Carnielli VP, Verlato G, Benini F, et al. Metabolic and respiratory effects of theophylline in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 2000;83(1):F39\u201343.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"63_CR45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1542\/peds.107.4.660","volume":"107","author":"J Bauer","year":"2001","unstructured":"Bauer J, Maier K, Linderkamp O, et al. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics. 2001;107(4):660\u20133.","journal-title":"Pediatrics"},{"issue":"3","key":"63_CR46","first-page":"123","volume":"138","author":"H Skopnik","year":"1990","unstructured":"Skopnik H, Koch G, Heimann G. Effect of methylxanthines on periodic respiration and acid gastroesophageal reflux in newborn infants [in German]. Monatsschr Kinderheilkd. 1990;138(3):123\u20137.","journal-title":"Monatsschr Kinderheilkd"},{"issue":"12","key":"63_CR47","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157\u201367.","journal-title":"N Engl J Med"},{"issue":"12","key":"63_CR48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/adc.54.12.946","volume":"54","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Collinge JM, Zinman R, et al. Maturation of caffeine elimination in infancy. Arch Dis Child. 1979;54(12):946\u20139.","journal-title":"Arch Dis Child"},{"issue":"5","key":"63_CR49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3476(78)80133-4","volume":"92","author":"BS Arant Jr","year":"1978","unstructured":"Arant BS Jr. Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr. 1978;92(5):705\u201312.","journal-title":"J Pediatr"},{"issue":"6","key":"63_CR50","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0009-9236(95)90021-7","volume":"58","author":"JN Anker van den","year":"1995","unstructured":"van den Anker JN, Schoemaker RC, Hop WC, et al. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age. Clin Pharmacol Ther. 1995;58(6):650\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"63_CR51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/000992280003900602","volume":"39","author":"J Bhatia","year":"2000","unstructured":"Bhatia J. Current options in the management of apnea of prematurity. Clin Pediatr. 2000;39(6):327\u201336.","journal-title":"Clin Pediatr"},{"issue":"17","key":"63_CR52","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.285.17.2199","volume":"285","author":"R Ramanathan","year":"2001","unstructured":"Ramanathan R, Corwin MJ, Hunt CE, et al. Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS. JAMA. 2001;285(17):2199\u2013207.","journal-title":"JAMA"},{"issue":"6","key":"63_CR53","first-page":"547","volume":"140","author":"CL Rosen","year":"1986","unstructured":"Rosen CL, Glaze DG, Frost JD Jr. Home monitor follow-up of persistent apnea and bradycardia in preterm infants. Am J Dis Child. 1986;140(6):547\u201350.","journal-title":"Am J Dis Child"},{"issue":"6","key":"63_CR54","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1542\/peds.108.6.1304","volume":"108","author":"JM Fiore Di","year":"2001","unstructured":"Di Fiore JM, Arko MK, Miller MJ, et al. Cardiorespiratory events in preterm infants referred for apnea monitoring studies. Pediatrics. 2001;108(6):1304\u20138.","journal-title":"Pediatrics"},{"issue":"6","key":"63_CR55","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0009-9236(97)90097-7","volume":"61","author":"TC Lee","year":"1997","unstructured":"Lee TC, Charles B, Steer P, et al. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Clin Pharmacol Ther. 1997;61(6):628\u201340.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"63_CR56","first-page":"170","volume":"16","author":"C Tayman","year":"2011","unstructured":"Tayman C, Rayyan M, Allegaert K. Neonatal pharmacology: extensive interindividual variability despite limited size. J Pediatr Pharmacol Ther. 2011;16(3):170\u201384.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"63_CR57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00003088-198409040-00002","volume":"9","author":"JH Jonkman","year":"1984","unstructured":"Jonkman JH, Upton RA. Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet. 1984;9(4):309\u201334.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"63_CR58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/AAC.33.4.474","volume":"33","author":"DP Healy","year":"1989","unstructured":"Healy DP, Polk RE, Kanawati L, et al. Interaction between oral ciprofloxacin and caffeine in normal volunteers. Antimicrob Agents Chemother. 1989;33(4):474\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"63_CR59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01736528","volume":"67","author":"A Holstege","year":"1989","unstructured":"Holstege A, Staiger M, Haag K, et al. Correlation of caffeine elimination and Child\u2019s classification in liver cirrhosis. Klinische Wochenschrift. 1989;67(1):6\u201315.","journal-title":"Klinische Wochenschrift."},{"issue":"26","key":"63_CR60","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJM197706302962603","volume":"296","author":"KM Piafsky","year":"1977","unstructured":"Piafsky KM, Sitar DS, Rangno RE, et al. Theophylline disposition in patients with hepatic cirrhosis. N Engl J Med. 1977;296(26):1495\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"63_CR61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2006-958163","volume":"24","author":"AE Leon","year":"2007","unstructured":"Leon AE, Michienzi K, Ma CX, et al. Serum caffeine concentrations in preterm neonates. Am J Perinatol. 2007;24(1):39\u201347.","journal-title":"Am J Perinatol"},{"issue":"1","key":"63_CR62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0031-3955(16)33965-7","volume":"28","author":"JV Aranda","year":"1981","unstructured":"Aranda JV, Grondin D, Sasyniuk BI. Pharmacologic considerations in the therapy of neonatal apnea. Pediatr Clin North Am. 1981;28(1):113\u201333.","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"63_CR63","first-page":"1124","volume":"44","author":"AJ Pesce","year":"1998","unstructured":"Pesce AJ, Rashkin M, Kotagal U. Standards of laboratory practice: theophylline and caffeine monitoring. National Academy of Clinical Biochemistry. Clin Chem. 1998;44(5):1124\u20138.","journal-title":"Clin Chem"},{"key":"63_CR64","unstructured":"Hivert V, B\u00e9cas-Garro MP. Lists of medicinal products for rare diseases in Europe. Orphanet Report Series, Orphan Drugs Collection. October 2013."},{"key":"63_CR65","doi-asserted-by":"crossref","unstructured":"Henderson-Smart DJ, De Paoli AG. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst Rev. 2010(12):CD000432.","DOI":"10.1002\/14651858.CD000432.pub2"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-013-0063-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0063-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:55:14Z","timestamp":1647892514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-013-0063-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s40272-013-0063-z","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}